Catalog Number | CBCL-0305 |
Price | Online Inquiry |
Unit Quantity | 1 x 10^6 cells / 1.0 ml |
This stable Ba/F3 cell line expresses an exogenous ETV6-BTK fusion gene with a C481S mutation and luciferase, facilitating studies of BTK signaling and activity.
Drug screening and biological assays
BTK C481S is a mutation in the Bruton's tyrosine kinase (BTK) gene that confers resistance to certain BTK inhibitors used in the treatment of B cell malignancies, by altering the drug-binding site.
Category | Luciferase Reporter Cell Lines |
Cell Line Name | Ba/F3-ETV6-BTK-C481S-Luc2-Stable Cell Line |
Protein Family | Bruton’s tyrosine kinase family |
Gene | BTK C481S |
NCBI Gene ID | 695 |
Species | Human |
Host Cell Line | Ba/F3 |
Cell Type | Murine pro-B cell line |
Morphology | Lymphoblastoid |
Growth Properties | Suspension |
Selection Marker | Hygromycin B |
Recommended Medium | RPMI1640+10%FBS+1000µg/mL Hygromycin B |
Freeze Medium | 70% RPMI1640+20% FBS+10% DMSO |
Storage Method | Frozen in liquid nitrogen. |
Stability | Validated for at least 10 passages |
Mycoplasma | Negative |
Sterility Testing | Negative |
Shipping | Shipping in dry ice |
Biosafety Level | BSL-1 |
Caution | For Research Use Only |